SCHEMBL10285683

SCHEMBL10285683

Cc1ccc(OCC(F)(F)F)cc1OCC(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.51
CYP2C9 P11712 3/20 0.49
KDM4E B2RXH2 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP17A1 P05093 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPT P10636 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
USP2 O75604 1/20 0.44
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
THRB P10828 1/20 0.44
G6PD P11413 1/20 0.44
ALOX15 P16050 1/20 0.44
CASP1 P29466 1/20 0.44
HSD17B10 Q99714 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GPR3 P46089 1/20 0.44
POLB P06746 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2031055 0.85 ALDH1A1 (0.55) ALDH1A1CYP2C9KDM4ECYP1A2CYP17A1
SCHEMBL24683493 0.85 CYP2C9 (0.49) ALDH1A1CYP2C9KDM4ECYP1A2CYP17A1
SCHEMBL24861798 0.85 TDP1 (0.45) MAPTMEN1KMT2AL3MBTL1GPR3
SCHEMBL23977888 0.83 CYP2C9 (0.58) ALDH1A1CYP2C9KDM4ECYP1A2MAPT
SCHEMBL15499295 0.81 CYP2C9 (0.46) ALDH1A1CYP2C9KDM4ECYP1A2CYP17A1
SCHEMBL12598685 0.81 FFAR1 (0.46) ALDH1A1CYP2C9KDM4ECYP1A2MAPT
SCHEMBL7336588 0.80 ALDH1A1 (0.52) ALDH1A1CYP2C9KDM4ECYP1A2MAPT
SCHEMBL3729825 0.80 DRD2 (0.47) ALDH1A1CYP2C9KDM4ECYP1A2CYP17A1
SCHEMBL17316513 0.80 HRH4 (0.44) ALDH1A1CYP2C9KDM4ECYP1A2CYP17A1
SCHEMBL23977887 0.79 CYP2C9 (0.50) ALDH1A1CYP2C9KDM4ECYP1A2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11693310-B2 Blue curable resin composition, blue color filter, and display device including same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-04 US disclosed
WO-2021145283-A1 COLORED CURABLE COMPOSITION 住友化学株式会社 2021-07-22 WO disclosed
US-9051397-B2 Oxime ester BASF SE (DE) 2015-06-09 US disclosed
US-9051397-B2 Oxime ester BASF SE (DE) 2015-06-09 US disclosed
EP-2625166-B1 OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS BASF SE (DE) 2014-09-24 EP disclosed
US-20130188270-A1 OXIME ESTER BASF SE (DE) 2013-07-25 US disclosed
US-20130188270-A1 OXIME ESTER BASF SE (DE) 2013-07-25 US disclosed
WO-2012045736-A1 OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS BASF SE (DE) 2012-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130188270-A1 OXIME ESTER CBR3, CBR1, COX15 ALDH1A1 738/4885CYP2C9 56/4885KDM4E 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.